New research underscores racial/ethnic diabetes disparities in the United States.
Earlier age at diabetes diagnosis among non-Hispanic Black and Mexican American adults can be attributed to a combination of clinical, behavioral, and social factors, researchers writing in JAMA Internal Medicine concluded.
This finding could contribute to observed disparities in diabetes-related microvascular and macrovascular complications and premature mortality, they added.
The prevalence of diabetes has substantially increased in the past 20 years in the United States. It generally occurs at a higher rate among non-Hispanic Black and Hispanic adults than non-Hispanic White adults, and because earlier onset is associated with more negative outcomes, investigators set out to compare self-reported age at diabetes diagnosis based on race/ethnicity in the United States.
The cross-sectional study included data from four 2-year cycles of the National Health and Nutrition Examination Survey. Responses were collected between 2011 and 2018. All participants were at least 20 years old and self-reported a history of diabetes and age of onset.
In addition, “self-reported race/ethnicity was assessed as a social construct to investigate health disparities,” the authors said, while they “determined the proportion of adults in each racial/ethnic group with age at diagnosis of diabetes before age 40, 35, and 30 years.”
All adults with a likely diagnosis of type 1 diabetes were excluded.
Of the included 3022 patients, 1586 were male and the mean (SD) patient age was 61.1 (0.3) years. A total of 946 participants were non-Hispanic White and the overall sample represented 22,844,326 adults.
Analyses revealed:
Overall, “the mean age at diabetes diagnosis was 4 to 7 years earlier in non-Hispanic Black and Mexican American adults than in non-Hispanic White adults,” the authors wrote. Over a quarter of non-Hispanic Black and Mexican American patients received the diagnosis before age 40.
The researchers noted the lack of differences observed between non-Hispanic White and non-Hispanic Asian populations could mask heterogeneity across Asian subgroups, marking a limitation to the study. The use of self-reported data is also subject to recall bias and does not include undiagnosed diabetes.
Based on the findings, “there may be benefit to initiating intensive lifestyle changes starting earlier in adulthood,” the researchers concluded. “Efforts to prevent and manage diabetes earlier in the life course may help reduce the substantial premature morbidity and mortality associated with diabetes.”
Reference
Wang MC, Shah NS, Carnethon MR, O’Brien MJ, Khan SS. Age at diagnosis of diabetes by race and ethnicity in the United States from 2011 to 2018. JAMA Intern Med. Published online September 7, 2021. doi:10.1001/jamainternmed.2021.4945
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Team-Based CINEMA Program Targets SDOH and Precision Care in Diabetes
December 20th 2024Ian Neeland, MD, discusses the CINEMA program's impact on addressing social determinants of health (SDOH) in Ohio and the importance of precision risk tests to reduce cardiovascular metabolic disease risk.
Read More